Balaji Amines Share Price

Balaji Amines Limited a leading Indian manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals, Pharma Excipients, Aliphatic Amines and Derivatives. Apart from this, it has now diversified into producing derivatives of methyl and ethyl amines, namely, Di-Methyl Amine Hydrochloride (DMA-HCl), Choline Chloride, Di Methyl Acetamide, etc. Balaji Amines share price on the NSE and BSE is a reflection of how market participants respond to a company’s performance and broader business developments within its industry. It captures the sentiment of the investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries.

The Balaji Amines stock price is influenced by various factors such as earnings, raw material costs, demand from end-user industries, and competitive pricing dynamics. In the longer run, strategies such as capacity expansion, product diversification, and margin stability affect stock market sentiments. All these factors must be closely monitored to have an idea about the Balaji Amines stock price movements.

Balaji Amines live share price provides real-time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant ͏monitoring of Balaji Amines live price helps observe short-term price fluctuations and understand how the stock is moving in relation to the broader market.

Furthermore, monitoring the Balaji Amines share͏ price today helps investors understand real-time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short-term performance, identify possible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook.

BALAJI AMINES LIMITED COMPANY FUNDAMENTALS

Balaji Amines Limited Company Background

Balaji Amines Limited (BAL) is an Indian specialty chemicals company engaged in the manufacture of aliphatic amines, including methylamines, ethylamines, their derivatives, and pharma excipients. Incorporated in 1988, the company commenced commercial production of methylamines in 1989 and subsequently expanded into ethylamines and downstream derivatives catering to the pharmaceutical, agrochemical, pesticide and other industrial sectors. BAL operates with a focus on value-based specialty chemicals and user-specific requirements. The company has progressively expanded its manufacturing capacities and refined its processes to ensure consistent product quality and cost efficiency. Amine manufacturing technology is globally restricted, and BAL was among the first in India to develop and commercialise indigenously tested amine technology, which has been enhanced over time. Its products meet stringent international quality standards and are supplied to global markets. BAL’s manufacturing facility is located at Tamalwadi village near Solapur, Maharashtra, and is equipped with advanced, digitally controlled systems for efficient process monitoring. The company also maintains in-house R&D and laboratory facilities to support process optimisation, product development and quality assurance. The company serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, pesticides and insecticides, water treatment chemical, optical brighteners, corrosion inhabitations, cosmetics, explosives, and foundry chemicals industries.

Balaji Amines Limited Company Product Lines

Amines

• Monomethylamine (MMA)
• Dimethylamine (DMA)
• Trimethylamine (TMA)
• Monoethylamine (MEA)
• Diethylamine (DEA)
• Triethylamine (TEA)
• Dimethyl Amino Ethanol (DMAE)
• Diethyl Amino Ethanol (DEAE)

Derivatives

• Di-Methyl Acetamide (DMAC)
• Di-Methyl Amine Hydrochloride (DMA HCL)
• Tri-Methyl Amine Hydrochloride (TMA HCL)
• Di-Ethyl Amine Hydrochloride (DEA HCL)
• Tri-Ethyl Amine Hydrochloride (TEA HCL)
• Mono-Ethyl Amine Hydrochloride (MEA HCL)
• Di-Methyl Urea (DMU)
• Choline Chloride 60% (Corn Cob)
• Choline Chloride 75% (Aqueous Solution)
• Choline Chloride 98% (Powder)
• Benzyl Tri Ethyl Ammonium Chloride (BTEAC)

Specialty Chemicals

• N-Methyl Pyrrolidone (NMP)
• Morpholine
• 2-Pyrrolidone (2-P)
• N-Ethyl-2-Pyrrolidone (NEP)
• Gamma-Butyrolactone (GBL)
• Dimethylformamide (DMF)
• Acetonitrile (ACN)
• Dimethyl Carbonate (DMC)
• Propylene Glycol (PG)
• Propylene Carbonate (PC)

Pharma Excipients

• Pharma-grade excipients (used across pharmaceutical formulations)

Balaji Amines Company Revenue Model

• Sale of Aliphatic Amines including methylamines and ethylamines to pharmaceutical, agrochemical, chemical, and industrial customers
• Revenue from derivatives of amines supplied as intermediates to pharma, pesticide, and specialty chemical manufacturers
• Sale of specialty chemicals and solvents used across pharmaceuticals, agrochemicals, coatings, batteries, and industrial applications
• Supply of pharma excipients to pharmaceutical formulation companies
• Contract manufacturing and customer-specific products based on defined technical specifications
• Domestic sales to Indian manufacturers across multiple industries
• Export sales to international customers through the company’s export division

Balaji Amines Geographic Presence

• Registered Office: Solapur, Maharashtra
• Administrative Office: Hyderabad, Telangana
• Manufacturing Facilities:
  • Unit I – Tamalwadi, Dharashiv district, Maharashtra
  • Unit II – Bollaram Industrial Area, Hyderabad, Telangana
  • Unit III – MIDC Chincholi, Solapur district, Maharashtra
  • Unit IV – MIDC Chincholi, Solapur district, Maharashtra

Balaji Amines Leadership 

Some of the key leaders of Balaji Amines as of January 2026 are

• Mr. Ande Prathap Reddy – Executive Chairman
• Mr. Rajeshwar Reddy Nomula – Whole-time Director
• Mr. Dundurapu Ram Reddy – Managing Director
• Mr. Ande Srinivas Reddy – Whole-time Director and Chief Financial Officer
• Dr. Suhasini Yatin Shah – Independent Director
• Dr. Uma Rajiv Pradhan – Independent Director
• Mr. Mohan Kumar Ramakrishna – Independent Director
• Mr. Adabala Seshagiri Rao – Independent Director

Balaji Amines Key Milestones

• 1988 – Incorporated on October 27; business operations commenced under KPR Group
• 1989 – Started production of Methyl Amines and Ethyl Amines
• 1992 – Established R&D Centre at Hyderabad
• 1995 – Launched Dimethyl Amine Hydrochloride; public issue raised ₹3.85 crore
• 1997-98 – Commercial operations of Ethyl Amines main plant commenced
• 2000 – Expanded into derivatives of Methyl and Ethyl Amines
• 2001 – ISO 9001 certification obtained; expansion into value-added products initiated
• 2003 – Awarded “Recognized Export House” status; increased Methyl Amines capacity
• 2005 – Developed additional specialty chemicals
• 2006 – Established Balaji Foundation; became sole manufacturer of GBL, NMP, Morpholine
• 2009-10 – Commissioned windmill, co-generation power plant, and PVP plant; export awards received
• 2012 – Secured EDQM, WHO-GMP, REACH certifications; won Export Excellence Award
• 2013 – Commissioned DMF and DMA-HCl plants; inaugurated five-star hotel
• 2014-15 – Green technology and hospitality excellence awards received
• 2016 – Set up Acetonitrile manufacturing plant
• 2017-18 – Subsidiaries amalgamated with BAL
• 2018-19 – Mega Project status granted; new specialty chemicals plant commissioned
• 2021-22 – Unit-IV Greenfield project and Ethylamines Phase I commissioned
• FY 2023 – DMC, PG, and PC plants commissioned at Unit-IV
• 2024-25 – Methylamines expansion, solar power plant, and electronic-grade DMC commissioned

Industry Perspective

Balaji Amines Limited operates in the chemical manufacturing industry, specifically within the aliphatic amines, specialty chemicals and chemical intermediates segment. These chemicals are critical building blocks used across a wide range of end-use industries including pharmaceuticals, agrochemicals, coatings, water treatment, personal care and industrial applications. The global amines market size was estimated at USD 22.84 billion in 2023 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 5.1% from 2024 to 2030. The rising surfactant demand and increased public awareness of health and food safety. This growth is driven by expanding pharmaceutical and agrochemical demand as well as wider industrial use. More recent industry forecasts suggest the amines industry could continue to expand at an approximate 7.8% CAGR from 2024 to 2030, reaching an estimated USD 23.5 billion by 2030 on the back of robust demand in pharmaceuticals, coatings, and industrial sectors. At a broader level, the global specialty chemicals market, of which amines are a key segment, is projected to grow from about USD 1.4 trillion in 2025 to USD 2.2 trillion by 2035 at a CAGR of around 5.0%, supported by industrial diversification and increased high-performance chemical use in Asia-Pacific, Europe and North America. These trends underline sustained long-term growth prospects for Balaji Amines’ products and markets.

Balaji Amines will benefit from rising demand for amines and specialty chemicals across pharmaceuticals, agrochemicals, and polymers. India’s push for domestic chemical manufacturing, import substitution, and China+1 sourcing strengthens its position. Capacity expansions, backward integration, and focus on value-added derivatives improve margins, scalability, and long-term growth visibility in global and domestic markets.

BALAJI AMINES LIMITED STOCK MARKET PRESENCE: LISTINGS & INDEX REPRESENTATION

Balaji Amines listed on the BSE (Bombay Stock Exchange) on April 5, 2007, and is traded on the NSE (National Stock Exchange) under the symbol BALAMINES, with the BSE scrip code 530999.

Balaji Amines Limited is an established entity in the Indian stock market, listed on major exchanges such as NSE and BSE. Its inclusion in prominent indices like S&P BSE Small Cap, S&P BSE 250 Small Cap Index, S&P BSE 400 Mid Small Cap Index, S&P BSE Mid Small Cap, S&P BSE Basic Materials, S&P BSE 500, S&P BSE All Cap, Nifty Microcap 250 Index, and Nifty Total Market underscores the company’s significance in India’s specialty chemicals sector.

The Balaji Amines stock price is tracked by investors. Its inclusion in these indices reflects its market capitalisation and scale in manufacturing amines and derivatives. Listing on NSE and BSE ensures liquidity, while index presence drives awareness within the chemicals sector.

Balaji Amines Limited Stock Performance and Share Price History

The Balaji Amines share price on NSE and BSE reflects its position as a leading manufacturer of aliphatic amines. Performance is driven by revenue growth, operating margins, raw material cost trends, and demand from pharmaceutical and agrochemical industries. Investors compare the Balaji Amines share price today with sectoral indices and peer companies to gauge relative performance.

These underlying factors are often visible through real market movements across different periods. Similar trends are observed during earnings-driven movements. Broader sector strength has also played a role in supporting the Balaji Amines share price. In addition to operational and sector-led factors, corporate actions can also have a significant impact on Balaji Amines share price movements short-term even when the company’s fundamentals remain strong.

While short-term movements reflect events and announcements, longer-term valuation trends are visible through the Balaji Amines share price 52-week high and low, providing context beyond daily or weekly changes. The 52-week high of ₹1,945 and low of ₹1,065.6 capture impacts of demand cycles, input cost pressures, and earnings visibility, providing context for the stock’s historical performance.

Balaji Amines’s stock performance reflects the trading behaviour of a specialty chemical manufacturer. The company’s product portfolio, captive plants, and focus on key industrial applications have shaped its Balaji Amines share price history. Over time, the stock has shown long-term wealth creation, marked by periods of sharp gains and phases of consolidation.

The early 2010s witnessed strong growth, particularly between 2012 and 2015, driven by expanding capacities and favourable industry demand. During 2020, the Balaji Amines stock price experienced high volatility, with a sharp correction in Q1 2020 followed by a strong recovery later that year. Between 2020 and 2021, Balaji Amines delivered high-return years, reflecting exceptional earnings growth during the period. From 2022 onwards, the Balaji Amines share price entered a corrective phase, mirroring broader margin pressures and normalization of demand, while recent performance points to continued market reassessment.

Balaji Amines’s stock performance over time has followed industry cycles and company-specific expansions. For instance, the Balaji Amines share price reached an all-time high above ₹5,223.55 in 2021, supported by peak profitability and strong investor confidence. Over longer investment horizons, the stock has delivered meaningful returns, including a gain of 777.7% over ten years, highlighting growth aligned with industrial chemical demand. However, returns over three and five years were negative 51.74% and positive 2.16%, respectively, reflecting recent corrections.

Recent periods show declines. The Balaji Amines share price decreased by 32.76% over one year, influenced by falling revenues and operating income. Over six months, it fell 35.14%, and over three months, it declined 18.97%. These decreases correspond with a 34.14% drop in operating income and a 29.59% fall in profit before tax for the latest fiscal year, alongside broader sectoral weakness. Despite COVID-19 disruptions, Balaji Amines shares showed resilience in 2020 and 2021 with strong gains, but subsequent years reflected margin normalization and lower earnings, impacting the Balaji Amines stock price.

Balaji Amines Limited Investor Relevance and Role in Portfolio

Balaji Amines is a holding in sector-specific and small-cap portfolios, offering exposure to specialty chemical manufacturing, amine derivatives, and industrial chemical demand. Inclusion in indices like S&P BSE Small Cap and Nifty Microcap 250 underscores its relevance within the basic materials segment. Its focus on captive production and key end-user industries makes it a choice for allocations targeting the chemical sector.

Balaji Amines equity is held by a mix of domestic and international institutional investors, reflecting its position in India’s chemical industry. Top institutional stakeholders include Government Pension Fund Global, Vanguard Group, and Dimensional Fund Advisors.

Prominent mutual fund holders include Motilal Oswal Mutual Fund’s Nifty Microcap 250 Index Fund. Global funds such as the Vanguard Total International Stock ETF, Vanguard FTSE Emerging Markets ETF, Vanguard FTSE All-World ex-US Small-Cap ETF, Avantis Emerging Markets Equity ETF, and Vanguard International Dividend Appreciation ETF also hold stakes. This investor base underscores the stock’s role in global emerging market and small-cap portfolios.

Beyond fundamentals and ownership, Balaji Amines’s stock is monitored in derivatives markets, where open interest and F&O quotes reflect expectations on earnings, margin trends, and sectoral demand. Technical indicators such as RSI, MACD, and MFI provide additional insight into short-term momentum shifts in Balaji Amines stock price. While primarily used for near-term trading, these tools can also help gauge market sentiment around major events.

Balaji Amines’s beta indicates higher volatility compared to the broader market. The long-term beta stands at 1.58. Over different periods, beta values range from a low of -0.054 on a daily three-month basis to a high of 1.96 on a weekly one-year basis. Other ranges include 1.41 for weekly two-year, 1.64 for two-week two-year, and 1.45 for monthly two-year. These figures, with a standard deviation of 9.39 for long-term price, show the Balaji Amines share price has experienced significant fluctuations, reflecting its sensitivity to market and sector movements.

Balaji Amines Limited Sectoral Relevance and Peer Positioning

Balaji Amines sector relevance stems from its scale in aliphatic and ethylamine production, captive manufacturing facilities, and vertical integration, establishing it as a key player supporting India’s specialty chemical ecosystem. Peer comparisons with Alkyl Amines Chemicals, Fineotex Chemical, BASF India, Galaxy Surfactants, and Vinati Organics focus on product mix, plant capacity, margin profiles, and client industries rather than short-term stock moves. These benchmarks help investors assess operational scale, efficiency, and positioning within the chemical supply chain. Institutional tracking of revenue growth, input costs, and demand from pharmaceuticals further highlights Balaji Amines’s importance within India’s broader industrial markets.

Balaji Amines’s sectoral importance is also reflected in financial and market metrics that demonstrate its scale, stability, and cyclical impact.

Balaji Amines P/E ratio demonstrates how the market values the company’s earnings relative to its profitability cycles. Historically, the P/E ratio has seen wide swings, from a low of 7.78 in March 2020 to a high of 32.35 in March 2024. The latest reported P/E is 24.83 for FY2025, a decrease of 23.25% from the previous year, showing valuation adjustments aligned with recent earnings pressure and broader chemical sector trends.

Alongside valuation, Balaji Amines EPS highlights operational performance and income generation from amine sales. Between 2019 and 2023, EPS increased significantly from ₹36.27 to ₹100.47, indicating strong earnings growth. In 2024 and 2025, annual basic EPS declined to ₹63.22 and ₹48.62, respectively, reflecting year-on-year decreases as revenue and margins normalized from earlier peaks. These trends correspond closely to industry demand cycles and raw material cost volatility, providing insight into the company’s performance relative to peers.

Balaji Amines market cap underscores its prominence within the chemical sector. The market cap has seen substantial growth over the long term, increasing from ₹376.06 million in November 2004 to ₹36.61 billion as of January 2026. However, it has decreased by 34.65% over one year. Annual market cap history shows ₹110.79B in 2021, ₹87.72B in 2022, ₹86.46B in 2023, ₹57.93B in 2024, and ₹36.24B in 2025, reflecting the recent downward trend in the Balaji Amines share price and valuation.

Finally, Balaji Amines’s earnings trajectory demonstrates cyclical growth tied to industry phases. Financial disclosures show net income rising from ₹4.58 crore in 2005 to ₹238.19 crore in 2021, with a sharp increase to ₹405.68 crore in 2023. Recent years show a decline, with net income at ₹204.85 crore in 2024 and ₹157.52 crore in 2025. These trends reflect the company’s sensitivity to chemical industry cycles, with periods of high profitability followed by consolidation, highlighting its positioning relative to other chemical manufacturers in India.

Summary

Balaji Amines Limited is a prominent manufacturer of aliphatic amines and specialty chemicals in India. The Balaji Amines share price reflects its operational performance, sectoral trends, and market sentiment. The company is listed on key stock exchanges and included in several indices. Its financial metrics, including earnings, EPS, and P/E ratio, show its historical growth and recent cyclical trends. Investors monitor the stock for exposure to the chemical sector, considering its volatility profile and position among industry peers.